Ionis Pharmaceuticals Revenue, Growth & Competitor Profile

DBA IONIS PHARMACEUTICALS, INC.
DBA ISIS PHARMACEUTICALS INC
DBA ISIS PHARMACEUTICALS, INC.

Company Profile & Annual Report for Ionis Pharmaceuticals

Access the complete profile.

Ionis Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	2855 Gazelle Court Carlsbad, CA 92010

Note: Revenues for privately held companies are statistical evaluations.


Ionis Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ionis Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Ionis Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ionis Pharmaceuticals Annual Revenue and Growth Rate

Ionis Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ionis Pharmaceuticals's revenues are gauged from an analysis of company filings.

Ionis Pharmaceuticals's Income Statement (based on Industry Averages)

Ionis Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Ionis Pharmaceuticals is developing and marketing. Ionis Pharmaceuticals doesn't have any recent trademark applications, indicating Ionis Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRYNGOLZA Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders, online journals, namely, blogs featuring information on genetic diseases and disorders; education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, online journals, namely, blogs featuring information on diseases and disorders of the cardiovascular, metabolic, neurological and inflammatory diseases and disorders	10/16/2023
TRYGAPOCE Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflammatory diseases and disorders	10/16/2023
DAWNZERA Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; online journals, namely, blogs featuring information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders	06/05/2023

See all trademarks and details in the Full Report.

Market Share of Ionis Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ionis Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Ionis Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SCRIPPS RESEARCH INSTITUTE	La Jolla, CA	100
IONIS PHARMACEUTICALS	Carlsbad, CA	69
SALK INSTITUTE FOR BIOLOGICAL STUDIES SAN DIEGO CALIFORNIA	La Jolla, CA	64
LA JOLLA INSTITUTE FOR IMMUNOLOGY	La Jolla, CA	32
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	La Jolla, CA	20
DIAGNOSTIC CONSULTING NETWORK	Carlsbad, CA	12

Future Competition: Ionis Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ionis Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)